Rauch G - Search Results

1

Multiplicity adjustment for composite binary endpoints.

Rauch G, Kieser M. Rauch G, et al. Methods Inf Med. 2012;51(4):309-17. doi: 10.3414/ME11-01-0044. Epub 2012 Apr 24. Methods Inf Med. 2012. PMID: 22525969

2

Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study.

Nikoghosyan AV, Rauch G, Münter MW, Jensen AD, Combs SE, Kieser M, Debus J. Nikoghosyan AV, et al. Among authors: rauch g. BMC Cancer. 2010 Nov 5;10:606. doi: 10.1186/1471-2407-10-606. BMC Cancer. 2010. PMID: 21050498 Free PMC article. Clinical Trial.

3

A new outlier identification test for method comparison studies based on robust regression.

Rauch G, Geistanger A, Timm J. Rauch G, et al. J Biopharm Stat. 2011 Jan;21(1):151-69. doi: 10.1080/10543401003650275. J Biopharm Stat. 2011. PMID: 21191861

4

Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.

Rauch G, Kieser M, Ulrich S, Doherty P, Rauch B, Schneider S, Riemer T, Senges J. Rauch G, et al. Among authors: rauch b. Eur J Prev Cardiol. 2014 Jan;21(1):74-80. doi: 10.1177/2047487312460518. Epub 2012 Sep 10. Eur J Prev Cardiol. 2014. PMID: 22964966

5

Planning and evaluating clinical trials with composite time-to-first-event endpoints in a competing risk framework.

Rauch G, Beyersmann J. Rauch G, et al. Stat Med. 2013 Sep 20;32(21):3595-608. doi: 10.1002/sim.5798. Epub 2013 Apr 2. Stat Med. 2013. PMID: 23553898

6

Opportunities and challenges of combined effect measures based on prioritized outcomes.

Rauch G, Jahn-Eimermacher A, Brannath W, Kieser M. Rauch G, et al. Stat Med. 2014 Mar 30;33(7):1104-20. doi: 10.1002/sim.6010. Epub 2013 Oct 13. Stat Med. 2014. PMID: 24122841

7

Easily applicable multiple testing procedures to improve the interpretation of clinical trials with composite endpoints.

Schüler S, Mucha A, Doherty P, Kieser M, Rauch G. Schüler S, et al. Among authors: rauch g. Int J Cardiol. 2014 Jul 15;175(1):126-32. doi: 10.1016/j.ijcard.2014.04.267. Epub 2014 May 9. Int J Cardiol. 2014. PMID: 24861257

8

Opportunities and challenges of clinical trials in cardiology using composite primary endpoints.

Rauch G, Rauch B, Schüler S, Kieser M. Rauch G, et al. Among authors: rauch b. World J Cardiol. 2015 Jan 26;7(1):1-5. doi: 10.4330/wjc.v7.i1.1. World J Cardiol. 2015. PMID: 25632312 Free PMC article.

9

Two-stage designs for cross-over bioequivalence trials.

Kieser M, Rauch G. Kieser M, et al. Among authors: rauch g. Stat Med. 2015 Jul 20;34(16):2403-16. doi: 10.1002/sim.6487. Epub 2015 Mar 24. Stat Med. 2015. PMID: 25809815

10

Blinded sample size recalculation in clinical trials with binary composite endpoints.

Sander A, Rauch G, Kieser M. Sander A, et al. Among authors: rauch g. J Biopharm Stat. 2017;27(4):705-715. doi: 10.1080/10543406.2016.1198371. Epub 2016 Jun 13. J Biopharm Stat. 2017. PMID: 27295402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters